In this manuscript, we used data from prior GBM trials to show how single arm trials compared to historic benchmarks can be misleading. Framework can be applied broadly. academic.oup.com/neuro-oncology…

La vignetta di makkox di oggi. Tutte le altre le trovate qui ilfoglio.it/makkox/2018/09…

When your much admired colleagues get recognized for their achievements, you have to tweet with unbounded happiness. So proud of my friend and colleague Veera Baladandayuthapani for this richly deserved recognition. Go Blue!

Best welcome ever! Ready to start as Harvard-MIT Center for Regulatory Science fellow and collaborate with this awesome team!

Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update - Rebecca S Slack Tidwell, S Andrew Peng, Minxing Chen, Diane D Liu, Ying Yuan, J Jack Lee, journals.sagepub.com/doi/abs/10.117…

Our new paper “Adaptive platform trials: definition, design, conduct and reporting considerations” in Nature Reviews Drug Discovery is free to view here rdcu.be/bPLEu Brian Alexander @statberry @RogerJLewis Kert Viele and many more #platformtrials #clinicaltrials nature.com/articles/s4157…

Lessons Learned from De-escalation trials in favorable risk HPV-associated Squamous Cell Head and Neck Cancer - A Perspective on future trial designs clincancerres.aacrjournals.org/content/early/…

I am so honored and humbled and looking forward to contribute to the National Academy of Medicine x.com/thenamedicine/…

Earlybird discounts for the Bayesian Adaptive Randomised #ClinicalTrials Workshop have been extended to Fri 7 Feb. Join international experts on adaptive trials, Lorenzo Trippa & Steffen Ventz from Harvard T.H. Chan School of Public Health In Melbourne 27-28 Feb and Sydney 5-6 Mar: buff.ly/398kPkZ

pCR & impact on breast cancer survival: largest meta-analysis to-date ⁦Clinical Cancer Research⁩. Mammoth effort led by Laura Spring Mass General Cancer Center Beverly Moy Andrea Arfè lorenzo trippa Dana-Farber #bcsm clincancerres.aacrjournals.org/content/early/…

Thanks! Excited to present the results of our study today!

Shared and Usable Data From Phase 1 Oncology Trials ja.ma/3cEn6po

New paper by David Robertson, myself and Frank Bretz on graphical approaches to controlling generalised error rates. Could be useful if you want to use a slightly less strict error rate than the family-wise error rate! onlinelibrary.wiley.com/doi/10.1002/si…

The first session of Junior Bayes Beyond the Borders (JB^3) organized by j-ISBA is happening now! Join me to listen François-Xavier Briol presenting his awesome work. FX is one of the ISBA Savage Awards finalist! bayeslab.unibocconi.eu/wps/wcm/connec…

New paper out on IBS Biometrics Journal! Joint work with lorenzo trippa and Brian Alexander. You are planning a RCT with a survival endpoint. Data from a previous trial suggests the proportional hazards assumption will fail. What are you going to do? (1/n) onlinelibrary.wiley.com/doi/10.1111/bi…

We are excited to honor alumnus and The Wharton School professor Dr. Eric Tchetgen Tchetgen as the recipient of the 2020 Myrto Lefkopoulou Distinguished Lectureship! He will deliver a virtual lecture on Sept 17, 1-2pm. More info here: hsph.me/myrto

Honored to have received the 2022 W.J. Youden Award together with Ruggero Bellio, Lorenzo Trippa lorenzo trippa, and Giovanni Parmigiani Giovanni Parmigiani ASA

Validation of Predictive Analyses for Interim Decisions in Clinical Trials ascopubs.org/doi/abs/10.120…

Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials. aacrjournals.org/clincancerres/… #btsm Clinical Cancer Research